Aalap Patel
About Aalap Patel
Aalap Patel is the Associate Director of US Access Marketing - Customer & Portfolio Value Generation, Oncology at Bristol Myers Squibb, with extensive experience in oncology marketing and strategy.
Company
Aalap Patel is currently with Bristol Myers Squibb, where he serves as the Associate Director for US Access Marketing - Customer & Portfolio Value Generation, Oncology. Throughout his tenure at Bristol Myers Squibb, Aalap has held multiple roles that have allowed him to showcase his expertise in oncology and strategy within the pharmaceutical industry.
Title
Aalap Patel holds the title of Associate Director, US Access Marketing - Customer & Portfolio Value Generation, Oncology at Bristol Myers Squibb. This role highlights his involvement in strategic marketing and portfolio management within the oncology sector.
Education and Expertise
Aalap Patel studied at the University of the Sciences in Philadelphia where he earned his Doctor of Pharmacy (PharmD) degree. His extensive educational background laid the foundation for a diverse and accomplished career in the pharmaceutical and healthcare industries. Aalap's expertise spans various domains including oncology marketing, health economics and outcomes research (HEOR), and medical strategy.
Background
Aalap Patel transitioned from boots-on-the-ground roles as a clinical pharmacist to strategic and leadership positions within the pharmaceutical industry. His early career included stints as a Pharmacist at Trinitas Regional Medical Center and a Pharmacy Manager at Walgreens. He further honed his clinical skills as a Clinical Pharmacist at Express Scripts. Aalap's journey within Bristol Myers Squibb began in 2015, where he has since held roles ranging from Field Medical in Immunoscience to HEOR Publications Lead in Hematology.
Achievements
Throughout his career, Aalap Patel has established a robust background in both hematology and immuno-oncology. At Bristol Myers Squibb, he has managed and led publication strategies for health economics and outcomes research (HEOR), underscoring his expertise in these areas. His roles have allowed him to gain a comprehensive understanding of the pharmaceutical landscape, with significant experience in field medical and strategic capacities.